Fagron NV acquired Wildlife Pharmaceuticals.
Fagron NV (ENXTBR:FAGR) completed the acquisition of Wildlife Pharmaceuticals during the quarter ended March 31, 2023.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
18.68 EUR | +1.19% | +2.19% | +12.46% |
Apr. 11 | Transcript : Fagron NV, Q1 2024 Sales/ Trading Statement Call, Apr 11, 2024 | |
Apr. 11 | Fagron Reports Revenue Results for the First Quarter Ended 31 March 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+12.46% | 1.45B | |
+33.43% | 700B | |
+27.63% | 569B | |
-5.12% | 358B | |
+19.59% | 330B | |
+4.89% | 287B | |
+16.27% | 236B | |
+6.67% | 202B | |
-9.33% | 197B | |
+4.26% | 161B |